Abstract
Four licensed enzyme immunoassay (EIA) kits for the measurement of antibody to human T-cell lymphotropic virus (HTLV) type 1, one from Organon Teknika Corp. (OTC), one from Cambridge Biotech Corp. (CBC), and two from Abbott Laboratories (the 1993 modification [Abb 93] and the 2.0 version licensed in 1995 [Abb 95]), were evaluated for sensitivity and specificity in the detection of HTLV type 2 antibody, and the results were compared with those previously obtained with earlier kit versions. The CBC, Abb 95, Abb 93, and OTC kits had sensitivities of 99.7, 97.6, 96.8, and 96.2%, respectively, compared with sensitivities of 89.1 and 60% for the Abbott and CBC (previously DuPont) kits, respectively, licensed in 1988. Thus, the abilities of commercial kits to detect HTLV antibody have improved. The relative specificities of the CBC, Abb 95, Abb 93, and OTC kits with negative blood donor specimens that had been reactive with the 1988 CBC EIA kit were 92.9, 64.5, 78.8, and 62.6%, respectively. Compared with those of the 1988 versions, the specificity of the Abbott EIA has decreased and the specificity of the CBC kit has been significantly improved.
Full Text
The Full Text of this article is available as a PDF (141.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cossen C., Hagens S., Fukuchi R., Forghani B., Gallo D., Ascher M. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II. J Clin Microbiol. 1992 Mar;30(3):724–725. doi: 10.1128/jcm.30.3.724-725.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallo D., Diggs J. L., Hanson C. V. Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II. J Clin Microbiol. 1990 Sep;28(9):2045–2050. doi: 10.1128/jcm.28.9.2045-2050.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallo D., Diggs J. L., Hanson C. V. Evaluation of two commercial human T-cell lymphotropic virus western blot (immunoblot) kits with problem specimens. J Clin Microbiol. 1994 Sep;32(9):2046–2049. doi: 10.1128/jcm.32.9.2046-2049.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallo D., Penning L. M., Diggs J. L., Hanson C. V. Sensitivities of radioimmunoprecipitation assay and PCR for detection of human T-lymphotropic type II infection. J Clin Microbiol. 1994 Oct;32(10):2464–2467. doi: 10.1128/jcm.32.10.2464-2467.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallo D., Penning L. M., Hanson C. V. Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method. J Clin Microbiol. 1991 Oct;29(10):2345–2347. doi: 10.1128/jcm.29.10.2345-2347.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kwok S., Gallo D., Hanson C., McKinney N., Poiesz B., Sninsky J. J. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses. 1990 Apr;6(4):561–565. doi: 10.1089/aid.1990.6.561. [DOI] [PubMed] [Google Scholar]
- Lillehoj E. P., Alexander S. S., Dubrule C. J., Wiktor S., Adams R., Tai C. C., Manns A., Blattner W. A. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide. J Clin Microbiol. 1990 Dec;28(12):2653–2658. doi: 10.1128/jcm.28.12.2653-2658.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]